Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
441.54
241.62
93.46
30.26
25.64
23.60
13.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
441.54
241.62
93.46
30.26
25.64
23.60
13.02
Raw Material Cost
179.66
87.63
28.19
9.10
9.28
9.96
7.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.41
10.79
3.73
3.87
3.98
4.35
2.72
Selling and Distribution Expenses
168.42
117.45
69.90
38.28
24.19
23.60
12.15
Other Expenses
4.16
2.53
2.31
1.84
1.46
1.53
1.09
Total Expenditure (Excl Depreciation)
404.04
241.14
124.90
69.69
52.02
53.21
33.25
Operating Profit (PBDIT) excl Other Income
37.5
0.5
-31.400000000000002
-39.4
-26.400000000000002
-29.6
-20.2
Other Income
12.69
12.85
-0.43
-0.88
1.65
0.79
0.09
Operating Profit (PBDIT)
69.95
21.61
-27.67
-37.66
-23.15
-27.59
-19.38
Interest
14.41
10.79
3.73
3.87
3.98
4.35
2.72
Exceptional Items
0.00
-29.21
-0.57
0.00
0.00
-0.34
-0.85
Gross Profit (PBDT)
261.88
153.99
65.27
21.16
16.36
13.64
5.57
Depreciation
19.76
8.28
4.20
2.65
1.58
1.22
0.77
Profit Before Tax
35.78
-26.67
-36.16
-44.18
-28.72
-33.51
-23.71
Tax
0.32
-1.64
0.07
0.04
0.03
0.04
0.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
35.46
-25.03
-36.23
-44.22
-28.75
-33.55
-23.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
35.46
-25.03
-36.23
-44.22
-28.75
-33.55
-23.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.46
-25.03
-36.23
-44.22
-28.75
-33.55
-23.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
228.60
137.20
187.38
67.85
103.89
54.65
-192.24
Earnings per share (EPS)
1.01
-0.77
-1.23
-1.6
-1.16
-2.36
-1.19
Diluted Earnings per share
1.01
-0.77
-1.23
-1.6
-1.16
-2.36
-1.19
Operating Profit Margin (Excl OI)
8.49%
0.2%
-33.64%
-130.29%
-102.91%
-125.42%
-155.47%
Gross Profit Margin
12.58%
-7.61%
-34.21%
-137.24%
-105.85%
-136.78%
-176.28%
PAT Margin
8.03%
-10.36%
-38.77%
-146.11%
-112.13%
-142.12%
-182.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 82.74% vs 158.40% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 242.00% vs 30.94% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 551.14% vs 132.35% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 33.33% vs 191.89% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of TransMedics Group, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
441.54
313.90
127.64
40.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
441.54
313.90
127.64
40.66%
Raw Material Cost
179.66
78.55
101.11
128.72%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.41
0.00
14.41
Selling and Distribution Expenses
168.42
194.69
-26.27
-13.49%
Other Expenses
4.16
5.33
-1.17
-21.95%
Total Expenditure (Excl Depreciation)
404.04
326.52
77.52
23.74%
Operating Profit (PBDIT) excl Other Income
37.50
-12.62
50.12
397.15%
Other Income
12.69
3.56
9.13
256.46%
Operating Profit (PBDIT)
69.95
-2.16
72.11
3,338.43%
Interest
14.41
0.00
14.41
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
261.88
235.36
26.52
11.27%
Depreciation
19.76
6.89
12.87
186.79%
Profit Before Tax
35.78
-9.05
44.83
495.36%
Tax
0.32
11.16
-10.84
-97.13%
Provisions and contingencies
0
0
0.00
Profit After Tax
35.46
-20.21
55.67
275.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
35.46
-20.21
55.67
275.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.46
-20.21
55.67
275.46%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
228.60
397.33
-168.73
-42.47%
Earnings per share (EPS)
1.01
-0.41
1.42
346.34%
Diluted Earnings per share
1.01
-0.41
1.42
346.34%
Operating Profit Margin (Excl OI)
8.49%
-4.02%
0.00
12.51%
Gross Profit Margin
12.58%
-0.69%
0.00
13.27%
PAT Margin
8.03%
-6.44%
0.00
14.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 44.15 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 82.74% vs 158.40% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 3.55 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 242.00% vs 30.94% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.73 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 551.14% vs 132.35% in Dec 2023
Annual - Interest
Interest 1.44 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 33.33% vs 191.89% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.49%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






